Medium composition for culturing porcine pluripotent stem cells

The culture medium with LDN-193189 and additional signaling molecules maintains pluripotency and promotes proliferation of porcine pluripotent stem cells, addressing feeder cell-dependent issues and ensuring stable culture without differentiation.

JP2024545483AActive Publication Date: 2024-12-06SPACE F CORP
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2024560217
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-03-13
Filing Date
2023-03-14
Publication Date
2024-12-06
Estimated Expiration
2043-03-14

AI Technical Summary

Technical Problem

Existing culture methods for porcine pluripotent stem cells rely on feeder cells, which pose issues like xenobiotic contamination and cell-to-cell variation, and fail to maintain pluripotency when adapted for feeder cell-free environments.

Method used

A culture medium composition for porcine pluripotent stem cells containing LDN-193189, optionally with FGF2, activin A, IWR-1, and CHIR99021, supports pluripotency without feeder cells by inhibiting the SMAD signaling pathway.

Benefits of technology

Maintains pluripotency and stem cell ability of porcine pluripotent stem cells in the absence of feeder cells, promoting proliferation and inhibiting differentiation, enabling stable and reproducible culture.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024545483000001_ABST
    Figure 2024545483000001_ABST
Patent Text Reader

Abstract

The present invention relates to a culture medium composition for porcine pluripotent stem cells. The culture medium composition of the present invention is capable of maintaining the pluripotency and stem cell activity of porcine pluripotent stem cells ex vivo for a long period of time, and enables the culture of stem cells independent of supporting cells.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] This application claims the benefit of priority based on Korean Patent Application No. 10-2022-0031249 filed on March 14, 2022 and Korean Patent Application No. 10-2023-0032368 filed on March 13, 2023, and incorporates all contents disclosed in the documents of said Korean patent applications as part of this specification. The present invention relates to a medium composition for culturing porcine pluripotent stem cells. [Background technology]

[0002] The acquisition and maintenance of pluripotency of stem cells is achieved or maintained by the activation of related genes through external factors such as metabolites, signal molecules and extracellular matrix (ECM). Metabolites such as carbohydrates, amino acids and lipids, as basic components required for culturing cells in vitro, regulate the physiological characteristics and pluripotency of stem cells. Various signaling molecules, including cytokines and hormones, play important roles in promoting the activation of cell signaling systems, supporting pluripotency and inhibiting differentiation of stem cells. It has been reported that pluripotency changes dynamically during embryonic development and constitutes a continuum consisting of multiple steps, such as naive, formative and primed types. It has been proven that pluripotency at each step is regulated by different combinations of signal molecules, and many efforts have been made to discover new molecules to maintain pluripotency.

[0003] The extracellular matrix is ​​composed of structural proteins such as collagen, laminin, and fibronectin, and provides a physical environment in which cells can attach and survive. Cells recognize extracellular matrix proteins through integrin receptors to regulate cell proliferation, survival, and aging. Feeder cells made from mouse fibroblasts have long been used for in vitro culture of pluripotent stem cells. The feeder cells are known to maintain the pluripotency of pluripotent stem cells by providing peripheral secretory factors and an adhesive ECM surface.

[0004] Although the use of feeder cells has advantages in culturing pluripotent stem cells in vitro, some problems related to xenobiotic contamination and cell-to-cell variation have been raised. Therefore, many studies have attempted to replace mouse fibroblast-derived feeder cells. First, conditioned media of mouse embryonic fibroblasts was used instead of feeder cells, or in human embryonic stem cell research, new culture conditions were developed using allogenic cells such as foreskin fibroblasts, endometrium-derived cells, and mesenchymal stem cells.

[0005] However, some culture conditions could not support the undifferentiated state of pluripotent stem cells due to the cell origin, but several proteome analyses confirmed that pluripotency-supportive feeder cells highly express various cytokines, including FGF2, TGFβ1, Activin A, and WNT. These molecules were proven to enhance the expression of pluripotency-related genes in pluripotent stem cells even in the absence of feeder cells.

[0006] Additionally, the possibility of replacing the extracellular matrix provided by the feeder cells with Matrigel or single components such as collagen, laminin, or fibronectin has been investigated.

[0007] Pig pluripotent stem cells, like embryonic stem cells, are considered to be a cell source applicable to agricultural biotechnology and comparative developmental biology research. However, many researchers have failed to establish pig embryonic stem cells because pigs have unique molecular biological characteristics compared to mouse and human embryos in the early preimplantation embryo development where pluripotency is established. In a previous invention, the researchers discovered various growth factors involved in pig pluripotency and developed a chemically defined medium containing a combination of new pig-specific growth factors. Using this medium together with mouse fibroblast-derived feeder cells, they established pig embryonic stem cells with in vivo differentiation potential for the first time in the world. However, they confirmed that when pig embryonic stem cells were cultured in an environment without feeder cells using the previously developed culture medium composition, they could not maintain pluripotency and differentiated.

[0008] Feeder cells made from mouse embryonic fibroblasts produce various cytokines, including fibroblast growth factor 2 (FGF2), transforming growth factor β1 (TGFβ1), activin A, WNT, oncostatin M and interleukin-6 (IL-6). Among them, FGF2 is used as a core element to maintain the pluripotency of human embryonic stem cells, and activin A, which is a standard for the quality of feeder cells, is abundant in the conditioned media in which mouse embryonic fibroblasts are cultured. In fact, a medium containing activin A and WNT helped to maintain the pluripotency of human embryonic stem cells in the absence of feeder cells. However, unlike human pluripotent stem cells in a feeder-free environment, FGF2, activin A or TGFβ1 and WNT antagonists failed to culture porcine embryonic stem cells in vitro under similar conditions. This demonstrates that in order to culture porcine embryonic stem cells in vitro without feeder cells, it is necessary to establish new culture conditions that include additional growth factors or signaling molecules.

[0009] Against this background, the inventors conducted extensive research into compositions for culturing porcine pluripotent stem cells, and discovered that when the culture composition of the present invention is used, it is possible to culture porcine pluripotent stem cells independent of feeder cells, thereby completing the present invention. [Prior art documents] [Patent documents]

[0010] [Patent Document 1] Korean Patent No. 10-2142400 (Registration Date: 2020.08.03.) [Non-patent literature]

[0011] [Non-Patent Document 1] Choi KH, Lee DK, Oh JN, Kim SH, Lee M, Woo SH, Kim DY, Lee CK. Pluripotent pig embryonic stem cell lines originating from in vitro-fertilized and parthenogenetic embryos. Stem Cell Res.2020 Dec;49:102093.

[0012] [Non-Patent Document 2] Choi KH, Lee DK, Oh JN, Kim SH, Lee M, Kim SW, Lee CK. Transcriptome profiling of pluripotent pig embryonic stem cells originating from uni- and biparental embryos. BMC Res Notes.2020 Mar 11;13(1):144.

[0013] [Non-Patent Document 3] Choi KH, Lee DK, Kim SW, Woo SH, Kim DY, Lee CK. Chemically Defined Media Can Maintain Pig Pluripotency Network In Vitro. Stem Cell Reports.2019 Jul 9;13(1):221-234. Summary of the Invention [Problem to be solved by the invention]

[0014] An object of the present invention is to provide a medium composition for culturing porcine pluripotent stem cells.

[0015] Another object of the present invention is to provide a method for culturing porcine pluripotent stem cells in a feeder cell-independent manner, using a medium composition for culturing porcine pluripotent stem cells. [Means for solving the problem]

[0016] To achieve the above object, the present invention provides a medium composition for culturing porcine pluripotent stem cells, comprising LDN-193189.

[0017] According to one embodiment of the present invention, the medium composition for culturing porcine pluripotent stem cells may further contain any one or more components selected from FGF2, activin A, IWR-1, and CHIR99021.

[0018] According to one embodiment of the present invention, the present invention provides a method for culturing porcine pluripotent stem cells using a medium composition for culturing porcine pluripotent stem cells, which contains LDN-193189.

[0019] According to one embodiment of the present invention, the present invention provides a culture medium additive composition for porcine pluripotent stem cells, comprising LDN-193189. Effect of the Invention

[0020] The medium composition for culturing porcine pluripotent stem cells according to the present invention can maintain pluripotency / stem cell activity even without feeder cells, thus eliminating problems that may arise from feeder cell-dependent culture methods. [Brief description of the drawings]

[0021] [Figure 1] This shows the cell morphology when porcine embryonic stem cells cultured without feeder cells were treated with various concentrations of LDN-193189 (magnification 100x). [Diagram 2] These are the results of an analysis of various gene expressions in porcine stem cells cultured without feeder cells (ff-ESCsLDN-., ff-ESCsLDN+) and porcine embryonic stem cells cultured with feeder cells (control). [Figure 2A] The results show immunological staining of pluripotency genes and the SMAD signaling system. [Figure 2B]The results show the expression levels of genes related to the SMAD signaling pathway secreted from supporting cells. [Figure 2C] qPCR analysis results for the expression of pluripotency marker genes. [Figure 2D] qPCR analysis results for the expression of trophectoderm marker genes. [Diagram 3] The optimal concentration of LDN-193189 was analyzed in porcine embryonic stem cells cultured without feeder cells. [Figure 3A] This shows the results of Annexin V staining with various concentrations of LDN-193189. [Figure 3B] 1 shows the results showing the cell death rate as a result of the Annexin V staining treatment. [Figure 3C] These are the results of the WST-8 assay. [Figure 3D] Ki-67 staining results. [Figure 4] qPCR analysis of pluripotency-related gene expression in LDN-193189-treated porcine embryonic stem cells cultured with various concentrations of FGF2, activin A, and CHIR99021. [Diagram 5] These are the results of an analysis of the characteristics of porcine embryonic stem cells cultured without feeder cells. [Figure 5A] Typical morphology and AP staining of porcine embryonic stem cells (lower row, AP staining image) (scale bar, 400 μm). [Figure 5B] This is the karyotype of porcine embryonic stem cells. [Figure 5C] Immunostaining results for pluripotency marker genes in porcine embryonic stem cells (scale bar, 200 μm). [Figure 5D] qPCR analysis results for the expression of pluripotency and differentiation marker genes in porcine embryonic stem cells cultured without feeder cells. [Figure 6] This relates to embryoid bodies derived from porcine embryonic stem cells cultured without feeder cells. [Figure 6A] Morphology of embryoid bodies derived from porcine embryonic stem cells (scale bar, 400 μm). [Figure 6B] qPCR analysis results for the expression of pluripotency and differentiation marker genes in porcine embryonic stem cells and differentiated cells. [Figure 7] 1 shows the results of histological analysis of teratomas formed from porcine embryonic stem cells. [Figure 8] The results of culturing porcine embryonic stem cells in various extracellular matrices, including fibronectin, laminin, poly-L-lysine, and type 1 collagen, are shown. [Figure 9] These are the results of an analysis of the function of LDN-193189 in a culture medium in which KSR was replaced with FBS. [Figure 10] These results show the effect of LDN-193189 on porcine embryonic stem cells cultured on feeder cells. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0022] The present invention will now be described in more detail.

[0023] All technical terms used in the present invention are used in the same sense as those generally understood by those of ordinary skill in the art unless otherwise defined. In addition, although preferred methods and samples are described herein, similar or equivalent methods and samples are also included within the scope of the present invention. The contents of all publications referenced herein are incorporated by reference in their entirety.

[0024] In describing and claiming particular features of the present disclosure, the following terminology will be used in accordance with the definitions set out below unless otherwise indicated.

[0025] It should be understood that although an embodiment may be described herein with the term "comprising," other similar embodiments described in terms of "consisting of" and / or "consisting essentially of" are also provided.

[0026] In the present invention, the terms "medium," "culture medium," "culture medium," "medium composition," or "culture composition" refer to a culture solution containing nutrients capable of supporting the growth and survival of stem cells under in vitro culture conditions, and may be used interchangeably herein without distinction.

[0027] In the present invention, "culturing porcine pluripotent stem cells" means cell proliferation of porcine pluripotent stem cells while maintaining pluripotency / stemness, without differentiating into cells of a specific lineage.

[0028] The porcine pluripotent stem cells may include pig embryonic stem cells or pig induced pluripotent stem cells, and the pluripotent stem cells may generally be obtained using any method known in the art.

[0029] In the present invention, the term "embryonic stem cells" refers to cells that may be pluripotent or totipotent, capable of differentiating into any tissue cell of an individual, which are obtained by extracting the inner cell mass from an embryo at the blastula stage, which is immediately before the fertilized egg is implanted in the uterus of the mother, and culturing them in vitro. In a broad sense, the term also includes embryoid bodies derived from embryonic stem cells. Embryoid bodies are intermediate structures formed by stem cells during the spontaneous differentiation process of embryonic stem cells into various tissue forms, and are aggregate forms formed during the culture of embryonic stem cells. Meanwhile, the embryonic stem cells of the present invention are porcine embryonic stem cells derived from pigs.

[0030] Embryonic stem cells may differentiate into ectodermal, mesodermal and endodermal stem cells.

[0031] In the present invention, the term "differentiation" refers to the phenomenon in which a cell's structure or function becomes specialized while the cell divides and grows. Pluripotent embryonic stem cells may differentiate into lineage-restricted precursor cells (e.g., ectodermal, mesodermal, or endodermal cells), and then further differentiate into other types of precursor cells (e.g., hemangioblasts), and then into terminally differentiated cells (e.g., vascular endothelial cells and vascular smooth muscle cells) that play characteristic roles in specific tissues (e.g., blood vessels).

[0032] Therefore, the pluripotency of the porcine pluripotent embryonic stem cells of the present invention can be analyzed by determining whether or not a certain number of porcine embryonic stem cells cultured using the medium composition of the present invention can differentiate into ectodermal, mesodermal and endodermal cells when transplanted into immunosuppressed mice.

[0033] In the present invention, the term "induced pluripotent stem cells" or "iPSCs" refers to cells that have been treated to give pluripotent differentiation to somatic cells or already differentiated cells. The treatment method includes, but is not limited to, the use of chemical compounds, genetic transformation, or culturing under specific conditions. "Porcine induced pluripotent stem cells" or "piPSCs" refers to cells that have been treated to give pluripotent differentiation to somatic cells or differentiated cells.

[0034] The term "subculture" as used herein means a method of culturing cells continuously for a long period of time in a healthy state by periodically transferring a portion of cells to a new culture vessel and then exchanging the culture medium. The term "passage" means the growth of pluripotent stem cells from the initial seed culture in a culture vessel to the stage of vigorous cell growth (confluence) in the same culture vessel. The number of cells increases in a culture vessel with a limited space, and after a certain period of time, the growth nutrients are consumed or contaminants accumulate, causing the cells to die naturally. This method is used to increase the number of healthy cells, and generally means exchanging the medium (culture vessel) once or culturing a group of cells separately, which is called one passage. The method of subculture may be any method known in the art without limitation, but may preferably be performed by mechanical or enzymatic separation.

[0035] The inventors of the present invention continued to conduct research using various methods in order to develop a medium composition for culturing porcine pluripotent stem cells, and as a result, developed a medium composition for culturing porcine pluripotent stem cells containing LDN-193189.

[0036] In one embodiment of the present invention, the LDN-193189 is contained at a concentration of 10 nM to 1000 nM.

[0037] In one embodiment of the invention, said porcine pluripotent stem cells are porcine embryonic stem cells or porcine induced pluripotent stem cells.

[0038] In one embodiment of the present invention, the medium composition for culturing porcine pluripotent stem cells may be used for feeder cell-independent culture of porcine pluripotent stem cells.

[0039] In one embodiment of the present invention, the support cell-independent culture is performed by culturing the cells in a culture vessel coated with extracellular matrix (ECM) or Matrigel (registered trademark) or a substitute thereof.

[0040] In one embodiment of the present invention, the feeder cell-independent culture is by culturing the cells in a culture vessel coated with fibronectin, laminin, poly-L-lysine, type 1 collagen or Matrigel (registered trademark).

[0041] In one embodiment of the present invention, the medium composition for culturing porcine pluripotent stem cells may further contain FGF2, Activin A, and CHIR99021.

[0042] In one embodiment of the present invention, the concentration of the FGF2 may be 0.1 ng / ml to 100 ng / ml, the concentration of the activin A may be 0.1 ng / ml to 10 ng / ml, the concentration of the CHIR99021 may be 0.1 μM to 4.5 μM, and the concentration of the IWR-1 may be 0.1 μM to 5 μM.

[0043] In one embodiment of the present invention, the medium composition for culturing porcine pluripotent stem cells promotes proliferation and inhibits cell death of porcine pluripotent stem cells.

[0044] In one embodiment of the present invention, the medium composition for culturing porcine pluripotent stem cells increases the number of porcine pluripotent stem cell colonies and increases the size of the colonies.

[0045] In one embodiment of the present invention, the medium composition for culturing porcine pluripotent stem cells enhances the stem cell potential / totipotency of porcine pluripotent stem cells.

[0046] In one embodiment of the present invention, the medium composition for culturing porcine pluripotent stem cells may be serum-free or contain 0.1 to 3% by weight of a serum component.

[0047] In one embodiment of the present invention, there is provided a composition for adding to a culture medium for porcine pluripotent stem cells, which comprises LDN-193189 as an active ingredient.

[0048] In one embodiment of the present invention, the LDN-193189 may be contained at a concentration of 10 nM to 1000 nM in the composition for adding to a culture medium for porcine pluripotent stem cells.

[0049] The present invention provides a method for culturing porcine pluripotent stem cells, comprising a step of treating porcine pluripotent stem cells with the culture medium composition for porcine pluripotent stem cells of the present invention and culturing the porcine pluripotent stem cells, wherein the porcine pluripotent stem cells are porcine embryonic stem cells or porcine induced pluripotent stem cells.

[0050] In one embodiment of the present invention, the method for culturing porcine pluripotent stem cells may involve culturing the stem cells in a feeder cell-independent manner.

[0051] In one embodiment of the present invention, the method for culturing feeder cells independent of each other may involve culturing cells in a culture vessel coated with an extracellular matrix (ECM) or Matrigel.

[0052] In one embodiment of the present invention, the feeder cell-independent culture may involve culturing cells in a culture vessel coated with fibronectin, laminin, poly-L-lysine, type 1 collagen or Matrigel.

[0053] The extracellular matrix may include fibronectin, laminin, poly-L-lysine, type 1 collagen, and other extracellular matrices commonly used in this technical field.

[0054] The medium composition for culturing porcine pluripotent stem cells of the present invention contains LDN-193189, which has the effects of promoting the proliferation or growth of porcine pluripotent stem cells, inhibiting stem cell death, increasing the number and size of stem cell colonies, and enhancing the stemness and differentiation ability of stem cells.

[0055] In the medium composition for culturing porcine pluripotent stem cells of the present invention, LDN-193189 may be added to the medium used for stem cell culture.

[0056] The LDN-193189 is a BMP (bone morphogenetic) pathway inhibitor, and is known to inhibit ALK1, ALK2, ALK3, and ALK6. LDN-193189 is known to induce differentiation of human pluripotent stem cells into neural progenitor cells or pancreatic cells, and is known to induce differentiation of mouse pluripotent stem cells.

[0057] However, in the present invention, it was discovered that LDN-193189 has the effect of maintaining stem cell potency / pluripotency of porcine pluripotent stem cells and inhibiting differentiation. This effect is the opposite of the effect of the conventional LDN-193189, which indicates that the mechanism for maintaining stem cell potency differs depending on the type of embryonic stem cell, and therefore the culture medium for embryonic stem cells should be changed depending on the type of the embryonic stem cell.

[0058] The concentration of LDN-193189 contained in the medium composition for culturing porcine pluripotent embryonic stem cells is 10 nM to 1000 nM. If the concentration of LDN-193189 is less than 10 nM, there is no special effect, and if it is more than 1000 nM, it shows cytotoxicity. The concentration of LDN-193189 contained in the medium composition for culturing porcine pluripotent embryonic stem cells according to one embodiment of the present invention is 100 nM, but is not limited thereto.

[0059] The medium composition for culturing porcine pluripotent stem cells of the present invention may further contain FGF2, activin A, CHIR99021, and IWR-1.

[0060] The FGF2, activin A, CHIR99021 and IWR-1 further contained in the medium composition for culturing porcine pluripotent stem cells according to one embodiment of the present invention have concentrations of 0.1ng / ml to 100ng / ml, 0.1ng / ml to 10ng / ml, 0.1μM to 4.5μM and 0.1μM to 5μM, respectively. When the concentration of FGF2 is less than 0.1ng / ml, there is no special effect, and when it exceeds 100ng / ml, there is no additional effect due to an increase in the concentration or it is toxic to cells. When the concentration of activin A is less than 0.1ng / ml, there is no special effect, and when it exceeds 10ng / ml, there is no additional effect due to an increase in the concentration or it is toxic to cells. When the concentration of CHIR99021 is less than 0.1μM, there is no special effect, and when it exceeds 4.5μM, it is toxic to cells. If the concentration of IWR-1 is less than 0.1 μM, there is no special effect, and if it exceeds 5 μM, there is no additional effect or it is toxic to cells. The FGF2, activin A, CHIR99021 and IWR-1 contained in the medium composition for culturing porcine pluripotent stem cells according to one embodiment of the present invention have concentrations of 20 ng / ml, 5 ng / ml, 0.5 μM and 0.5 μM, respectively, but are not limited thereto.

[0061] The basal medium for the culture medium of the porcine pluripotent stem cells of the present invention may be any medium widely known to those skilled in the art without any limitations. The basal medium may be artificially synthesized or may be a commercially produced medium. Examples of commercially produced media include, but are not limited to, DMEM (Dulbecco's Modified Eagle's Medium), MEM (Minimal Essential Medium), BME (Basal Medium Eagle), RPMI 1640, F-10, F-12, α-MEM (α-Minimal essential Medium), G-MEM (Glasgow's Minimal Essential Medium), IMDM (Isocove's Modified Dulbecco's Medium), and DMEM / F-12.

[0062] In one embodiment of the present invention, DMEM / F-12 basal medium is used.

[0063] In the culture medium composition of the present invention, it is preferable to further use an antibiotic, an antifungal agent and / or a substance that is generally used in the art to prevent infection with bacteria, fungi, etc. As the antibiotic, any antibiotic that is generally used in cell culture, such as penicillin-streptomycin, may be used, and as the antifungal agent, commonly used substances such as alporelicin B and as the mycoplasma inhibitor, gentamicin, ciprofloxacin, azithromycin, etc. may be used, but are not limited to these. In addition, a commercially available antibiotic-antimycotic (AA) (Gibco) may be used.

[0064] The culture composition of the present invention may also contain 1% Glutamax (or glutamine) and 0.1 mM β-mercaptoethanol.

[0065] The medium composition for culturing porcine pluripotent stem cells of the present invention may be used for feeder cell-independent culture of porcine pluripotent stem cells.

[0066] Generally, when culturing pluripotent stem cells or embryonic stem cells, feeder cells such as mouse fibroblasts have been used to maintain pluripotency or stem cell activity (feeder cell-dependent culture), but there are problems such as foreign body contamination / cell-to-cell variation, and attempts have been made to mass-culture pluripotent stem cells in a feeder cell-independent manner. However, in the case of porcine pluripotent stem cells, when a feeder cell-independent culture medium used for human embryonic stem cells is used, pluripotency / stem cell activity is not maintained. However, when the medium composition for culturing porcine pluripotent stem cells of the present invention is used, it has been confirmed that the pluripotency / stem cell activity of porcine pluripotent stem cells is maintained even without feeder cells.

[0067] Furthermore, the medium composition for culturing porcine pluripotent stem cells of the present invention may be serum-free or contain 0.1 to 3% by weight of a serum component.

[0068] The serum-free medium refers to any culture medium that does not contain a certain amount or more of serum derived from animals, including humans (animal-derived serum).For example, the serum-free medium may contain less than 0.1% by weight or less than 0.01% by weight of serum derived from animals based on the total composition content, and specifically, may not contain serum derived from animals.

[0069] The present invention provides a culture medium additive composition for porcine pluripotent stem cells, which contains LDN-193189 as an active ingredient.

[0070] By using the composition of the present invention, porcine pluripotent stem cells can be stably proliferated and cultured, making it possible to establish reproducible testing and production processes.

[0071] The present invention also relates to a method for culturing porcine pluripotent stem cells, comprising the step of treating porcine pluripotent stem cells with the medium composition for culturing porcine pluripotent stem cells of the present invention and culturing the cells.

[0072] The porcine pluripotent stem cells may be cultured in a feeder cell-independent manner, in which case the porcine pluripotent stem cells may be cultured in a culture vessel coated with an extracellular matrix or Matrigel (registered trademark) or a substitute therefor (gelatin, collagen, laminin, fibronectin, poly-D-lysine, poly-L-lysine, etc.), but is not limited thereto.

[0073] Unless otherwise stated, all numbers used in the specification and claims, whether or not they are referred to, should be understood to be expressed in all cases by the term "about". It should also be understood that the exact numerical values ​​used in the specification and claims form additional embodiments of the present disclosure. Although efforts have been made to ensure the accuracy of the numerical values ​​disclosed in the embodiments, all measured numerical values ​​may inherently contain certain errors resulting from the standard deviations measured with the respective measuring techniques.

[0074] The present invention will be described in more detail below with reference to examples. These examples are merely for the purpose of explaining the present invention in more detail, and it will be obvious to those skilled in the art that the scope of the present invention is not limited to these examples in accordance with the gist of the present invention. EXAMPLES

[0075] Example 1. Analysis of the culturing ability of porcine embryonic stem cells by culture medium Example 1-1. Isolation of porcine embryonic stem cells Animal care and experimental use were approved by the Seoul National University Laboratory Animal Ethics Committee (IACUC) (approval numbers: SNU-191025-4-4 and SNU-201019-1-2). Pregnant ICR mice and athymic nude mice were purchased from Samtaco Bio Inc. (Korea) and OrientBio Inc. (Korea), respectively. Mice were maintained according to standard protocols at the Seoul National University Laboratory Animal Resources and Management Center.

[0076] Isolation of porcine embryonic stem cells from blastocysts and production of feeder cells using mouse fibroblasts were performed according to the method of KR10-2142400.

[0077] Example 1-2. Feeder-dependent culture of porcine embryonic stem cells The "embryonic stem cell culture medium" used to culture porcine embryonic stem cells together with feeder cells is a DMEM / F12-based medium supplemented with 15% (v / v) knock-out serum replacement (KSR), 0.1% (v / v) chemically defined lipid concentrate (LC), 1X GlutaMAX®, 0.1 mM β-mercaptoethanol, 1X MEM non-essential amino acids, and 1X antibiotics-antimycotics (all the aforementioned substances were purchased from Gibco, Gaithersburg, MD, USA), 20 ng / mL hrFGF2 (fibroblast growth factor 2) (R&D Systems, Minneapolis, MN, USA), 5 ng / mL ActA (activin A) (R&D Systems), 1.5 μM CHIR99021 (CH, Cayman Chemical, Ann Arbor, NC, USA), and 10 μM erythrocyte sedimentation medium (ESM). Arbor, MI, USA) and 2.5 μM IWR-1 (Sigma-Aldrich, St. Louis, MO, USA).

[0078] Porcine embryonic stem cells were subcultured every 5 to 7 days together with feeder cells. 24 hours before subculture, porcine embryonic stem cells were cultured in the aforementioned "embryonic stem cell culture medium" containing 10 μM Y-27632 (Santa Cruz Biotechnology, Dallas, TX, USA). Fully grown embryonic stem cell groups were separated into small clumps using TrypLE® Express (Gibco). These cell clumps were transferred to new feeder cells and cultured in "embryonic stem cell culture medium" containing 10 μM Y-27632 (Santa Cruz Biotechnology) for 24 hours. After 24 hours, the embryonic stem cells attached to the feeder cells were cultured in "embryonic stem cell culture medium" without Y-27632 for 4 to 6 days. The medium was changed every 24 hours and incubated at 5% CO 2 , and cultured at 37°C.

[0079] Example 1-3. Feeder-independent culture of porcine embryonic stem cells For feeder-free culture of porcine embryonic stem cells, the porcine embryonic stem cells cultured with feeder cells were cultured in embryonic stem cell culture medium for feeder-independent culture (hereinafter referred to as "FF-embryonic stem cell culture medium") at a split ratio of 1:5 to 1:10 in the matrix. TM The cells were cultured on culture dishes coated with 1H-C14 (SPL Life Sciences, Pocheon, Korea).

[0080] FF-embryonic stem cell culture medium is a DMEM / F12-based medium containing 15% (v / v) KSR, 0.1% (v / v) LC, 1X Glutamax, 0.1 mM β-mercaptoethanol, 1X MEM non-essential amino acids, and 20 ng / mL hrFGF2 (R&D Systems), 5 ng / mL ActA (R&D Systems), 1.5 μM CHIR99021 (CH, Cayman Chemical), 2.5 μM IWR-1 (Sigma-Aldrich), 1X antibiotics-antimycotics (all the aforementioned substances were purchased from Gibco, Gaithersburg, MD, USA), and 100 nM LDN-193189 (Cayman Chemical).

[0081] Porcine embryonic stem cells were subcultured every 5 to 7 days. 24 hours before subculture, the porcine embryonic stem cells were cultured in "FF-embryonic stem cell culture medium" containing 10 μM Y-27632 (Santa Cruz Biotechnology, Dallas, TX, USA). The cultured stem cells were then separated into small clumps using TrypLE® Express (Gibco). The cells were then transferred to a new Matrix. TM The cells were transferred to a coated dish and cultured for 24 hours in "FF-embryonic stem cell culture medium" containing 10 μM Y-27632 (Santa Cruz Biotechnology). The attached stem cells were then cultured for 4 to 6 days in "FF-embryonic stem cell culture medium" without Y-27632. The medium was changed every 24 hours and incubated at 5% CO 2 , and cultured at 37°C.

[0082] Example 1-4. Analysis of the effect of LDN-193189 on feeder-independent culture of porcine embryonic stem cells (cell morphology analysis) To analyze the effect of the ALK2 / 3 inhibitor LDN-193189 in feeder-independent cultures of porcine embryonic stem cells, we confirmed the cytotoxicity of LDN-193189 by Annexin V staining (Figure 1). To find the optimal concentration for LDN-193189 treatment, we performed a concentration-dependent cytotoxicity experiment, and Annexin V staining showed that LDN-193189 at 1000 nM or higher was highly cytotoxic. Furthermore, treatment for 24 hours or more at a concentration of 1000 nM or higher induced the death of most cells.

[0083] Example 1-5. Analysis of the effect of LDN-193189 treatment on feeder-independent culture of porcine embryonic stem cells (gene expression analysis) To analyze the expression levels of pluripotency-related genes and differentiation-related genes depending on the culture period, porcine embryonic stem cells were cultured in "FF-embryonic stem cell culture medium" (ff-ESCs) containing 100 nM LDN-193189 without feeder cells. LDN+ ), and "FF-embryonic stem cell culture medium" (ff-ESCs) without LDN-193189 LDN- As a control, porcine embryonic stem cells were cultured together with feeder cells in the aforementioned embryonic stem cell culture medium (Control ESCs).

[0084] After plating with the respective media, cells were obtained on days 2, 4, and 6. Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, USA), and cDNA was synthesized using the High-Capacity RNA-to-cDNA Kit (Applied Biosystems, Foster City, USA). cDNA was amplified using the primer sets listed in Table 1 and the DyNAmo HS SYBR Green qPCR kit (Thermo Fisher Scientific, Waltham, USA).

[0085] [Table 1]

[0086] As shown in Figure 2, changes in the characteristics of porcine embryonic stem cells were confirmed during feeder cell-independent culture. Figure 2A shows the results of immunological staining of pluripotency genes and the SMAD signaling system, and Figure 2B shows the expression levels of SMAD signaling system-related genes secreted from feeder cells.

[0087] When porcine embryonic stem cells are cultured, removal of essential supporting cells results in the loss of stem cell potential and induction of differentiation into other cells. In the case of early embryos, they are programmed to differentiate into mesodermal tissues, and we confirmed the expression of SMAD signaling proteins, one of the signaling pathways involved in this process. We confirmed the expression of phosphor-SMAD2 / 3 proteins, which are involved in stem cell proliferation, as well as phosphor-SMAD1 / 5 proteins, which are involved in differentiation. In fact, we confirmed the expression of various genes (Grem1, Grem2, Chrd, Nog) that suppress the activity of this signaling pathway in supporting cells involved in maintaining the pluripotency of embryonic stem cells (Figures 2A and 2B).

[0088] Furthermore, as shown in Figures 2C and 2D, the effect of treatment with LDN-193189 (250 nM), an inhibitor of the SMAD1 / 5 signaling pathway, on feeder cell-independent culture of porcine embryonic stem cells was confirmed.

[0089] To verify the hypothesis that SMAD1 / 5 signaling inhibitors secreted from feeder cells are useful for maintaining the pluripotency of porcine embryonic stem cells, we treated porcine embryonic stem cells cultured without feeder cells with LDN-193189, an inhibitor of the SMAD1 / 5 signaling system, and confirmed that genes involved in pluripotency and mesodermal tissue development, which were altered when feeder cells were removed, were restored to the levels observed when cultured on feeder cells.

[0090] Example 2. Analysis of the optimal concentration of LDN-193189 and the effects of different concentrations of FGF2, activin 2, and CHIR99021 on feeder-independent culture of porcine embryonic stem cells Example 2-1. Analysis of optimal concentration of LDN-193189 To confirm the optimal concentration of "FF-embryonic stem cell culture medium" containing LDN-193189 between 100nM and 1000nM, Annexin V staining was performed at each concentration (Figure 3A). At concentrations of 750nM or higher, a significant increase in cell death rate was confirmed (Figure 3B). Although no significant difference was observed in the Ki-67 staining results between 100nM and 1000nM (Figure 3D), the results of WST-8 confirmed a significant decrease in cell activity at concentrations of 500nM or higher (Figure 3C). In fact, LDN-193189 is known to suppress the activin A signaling system involved in stem cell proliferation at high concentrations. Therefore, the final treatment concentration was determined to be 100nM, which is the maximum concentration that suppresses only the BMP signaling system and does not cause cytotoxicity.

[0091] Example 2-2. Analysis of FGF2, Activin 2, and CHIR99021 by concentration To optimize the concentration of signaling substances in the culture medium, FGF2, activin A, CHIR99021, and IWR-1 were added at various concentrations (Figures 4A and 4B). Figure 4A shows the proliferation rate as determined by Ki-67 staining, and Figure 4B shows cell activity as determined by WST-8 assay.

[0092] The proliferation rate was confirmed by Ki-67 staining, and the percentage of cells undergoing cell division gradually increased as the concentration of FGF2 increased. However, the simultaneous measurement of cell proliferation and cytotoxicity by WST-8 assay confirmed that at concentrations of 100ng / ml or more, cell activity decreased due to cytotoxicity.

[0093] The results of Ki-67 staining and WST-8 assay confirmed that activin A reduced cytotoxicity and proliferation rate at concentrations of 10 ng / ml or more, and therefore confirmed that the optimal concentration of activin A was 1 ng / ml to 5 ng / ml.

[0094] The proliferation rate of CHIR99021 gradually decreased with increasing concentration compared to the group not treated with CHIR99021. However, the results of WST-8 confirmed that the activity and proliferation rate of stem cells were improved when the substance was treated at a concentration of 0.1μM to 0.5μM.

[0095] The percentage of dividing cells gradually increased with increasing IWR-1 concentration, but it was cytotoxic at higher concentrations, with the highest cellular activity observed at 0.5 μM IWR-1.

[0096] Example 3. Characterization of porcine embryonic stem cells cultured without feeder cells For immunocytochemical analysis of porcine embryonic stem cells cultured without feeder cells, cell samples were left at 4°C for 10 min and then fixed with 4% (w / v) paraformaldehyde for 30 min. After washing twice with DPBS (Dulbecco's phosphate buffered saline), samples were treated with DPBS containing 10% (v / v) goat serum for 1 h to prevent nonspecific binding. Serum-treated cells were subjected to immunocytochemical analysis with OCT4 (1:200; SC-9081, Santa Cruz Biotechnology), SOX2 (1:200; AB5603, Millipore, Billerica, MA, USA), NANOG (1:200; 500-P236, Peprotech, NJ, USA), SSEA1 (1:200; MAB4301, Millipore), and SSEA4 (1:200; MAB4304, Millipore). For nuclear proteins (e.g., OCT4, SOX2, and NANOG), fixed cells were treated with 0.1% (v / v) Triton X-100 (Sigma-Aldrich) for 15 min before serum treatment before applying antibodies. After primary antibody treatment, Alexa Fluor-conjugated secondary antibodies were treated for 3 h at room temperature. Cell nuclei were confirmed with Hoechst 33342 (Molecular Probes, Eugene, OR, USA). Experimental results were visualized using images of stained cells using an inverted fluorescence microscope (Eclipse TE2000-U, Nikon, Konan, Japan).

[0097] For alkaline phosphatase (AP) staining, cells were fixed in 4% (w / v) paraformaldehyde for 30 min and stained with a buffer containing nitro blue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl phosphate toluidine salt stock solution (Roche, Basel, Switzerland) for 30 min at room temperature. Stained cells were visualized under an inverted microscope.

[0098] The appearance of the porcine embryonic stem cell colony cultured in the "embryonic stem cell culture medium" containing LDN-193189 in a Matrigel (registered trademark)-coated culture vessel without feeder cells was a flat monolayer, similar to the porcine embryonic stem cell colony cultured with feeder cells, and showed epithelial cell morphology with a high nucleus-to-cytoplasm ratio, i.e., typical embryonic stem cell morphology (Figure 5A). In addition, the stem cells cultured without feeder cells had a normal karyotype (36+XX) (Figure 5B) and were stably maintained during long-term culture (more than 10 passages).

[0099] Stem cells cultured without feeder cells showed alkaline phosphatase activity (Figure 5A, bottom), and expressed pluripotency markers (proteins) such as OCT4, SOX2, NANOG, SSEA1 and SSEA4, similar to porcine embryonic stem cells cultured with feeder cells (Figure 5C). qPCR analysis showed that pluripotency-related genes and trophoblast differentiation-related genes such as OCT4, SOX2 and NANOG were stably expressed compared to the genes of control porcine embryonic stem cells during long-term culture without feeder cells (Figure 5D).

[0100] (IVF-ES-11, PG-ES-3: porcine embryonic stem cell line, W / feeder: group cultured on feeder cells, W / O feeder: feeder-independent culture group)

[0101] Example 4. Analysis of the differentiation potential of porcine embryonic stem cells by culture medium Example 4-1. Differentiation induction of porcine embryonic stem cells using the embryoid body method Embryonic stem cells cultured without feeder cells were dissociated into single cells using TrypLE Express (Gibco) and cultured in suspension for 5 days in DMEM containing 15% (v / v) FBS and 10 μM Y-27632 (treated only on day 1) without other cytokines. After suspension culture, dissociated cells aggregated to form embryoid bodies, which were then cultured as adherent cells for 2 to 3 weeks in DMEM containing 15% (v / v) FBS on a culture dish coated with 0.1% (w / v) gelatin.

[0102] Porcine embryonic stem cells cultured without feeder cells formed embryoid bodies in suspension culture, which then attached to culture dishes and differentiated spontaneously (Figure 6A). Upon in vitro differentiation, porcine embryonic stem cells highly expressed three germ layer markers (PAX6 [ectoderm], AMY2 [endoderm], and BMP4 [mesoderm]), but pluripotency marker genes were gradually downregulated as analyzed by qPCR (Figure 6B).

[0103] (IVF-ES-11, PG-ES-3: porcine embryonic stem cell line, ESC: embryonic stem cell, Ebs: embryoid body, Diff.: embryoid body differentiated in vitro by attachment to culture dish)

[0104] Example 5. Analysis of teratoma formation Approximately 5-10Х 10 of porcine embryonic stem cells cultured without feeder cells 6 The porcine stem cells were resuspended in 200 μL of "embryonic stem cell culture medium" containing 50% (v / v) BD Matrigel Matrix (BD Biosciences, Franklin Lakes, NJ, USA) and 10 μM Y-27632. The resuspended porcine stem cells were then injected subcutaneously into 5-week-old athymic nude mice (OrientBio). Two to three months after implantation, 1-2 cm teratomas were harvested, fixed in 4% (w / v) paraformaldehyde, embedded in paraffin, and then stained with hematoxylin and eosin for light microscopy.

[0105] As a result, we repeatedly confirmed that porcine embryonic stem cells cultured without feeder cells differentiated into teratomas when subcutaneously transplanted into immunodeficient mice (nude mice). The teratomas were histologically composed of various tissues that showed three germ layers (Figure 7). Therefore, we confirmed that porcine embryonic stem cells cultured without feeder cells also have pluripotent differentiation ability (ectoderm, mesoderm, endoderm).

[0106] Example 6. Analysis of culture media with various extracellular matrices To evaluate the feasibility of using various extracellular matrices (ECMs) in culture media for support-independent culture of porcine embryonic stem cells, we attempted to culture the stem cells in cell culture dishes coated with fibronectin, laminin, poly-L-lysine, and type 1 collagen. Figure 8 shows the results of culturing porcine embryonic stem cells cultured in various extracellular matrices, including fibronectin, laminin, poly-L-lysine, and type 1 collagen.

[0107] Immunohistochemical staining of the pluripotency markers NANOG and SSEA4 revealed that there was a bias in cell characteristics such as pluripotency and proliferation ability due to the extracellular matrix, but it was confirmed that the characteristics of porcine embryonic stem cells could be maintained on various substrates by using the new culture medium.

[0108] Example 7. Analysis of culture conditions containing fetal bovine serum (FBS) We confirmed that treatment with LDN-193189 in a medium containing KSR, a serum replacement agent, is effective in feeder-independent culture of porcine embryonic stem cells.

[0109] In addition, we confirmed whether the substance is useful for maintaining the pluripotency of porcine embryonic stem cells in a culture medium containing fetal bovine serum (FBS), which is not a serum replacement. Figure 9 shows the results of analyzing the function of LDN-193189 in a culture medium in which KSR was replaced with FBS. Figure 9A shows the results of analyzing the characteristics of porcine embryonic stem cells through the pluripotency markers NANOG and SSEA4 (white dotted line: differentiated area), and Figure 9B shows the changes in expression of genes related to pluripotency and mesodermal tissue development in a culture medium containing FBS with or without LDN-193189 treatment.

[0110] Immunohistochemical staining of pluripotency markers NANOG and SSEA4 revealed that culture medium containing FBS induced differentiation of porcine embryonic stem cells, and many cell populations with reduced expression of NANOG and SSEA4 were found. This phenomenon was confirmed to be alleviated by treatment with LDN-193189, and qPCR analysis showed that treatment with LDN-193189 in an FBS-containing environment reduced the expression of mesoderm-related genes, which is helpful in maintaining stem cell pluripotency.

[0111] Example 8. Confirmation of usability under culture conditions in the presence of supporting cells The effect of a medium for feeder-independent culture containing LDN-193189 on porcine embryonic stem cells cultured on feeder cells was confirmed.

[0112] FIG. 10 shows the effect of LDN-193189 on porcine embryonic stem cells cultured on feeder cells. FIG. 10A shows the expression of pluripotency markers (NANOG, SSEA4) in porcine embryonic stem cells cultured on feeder cells treated with LDN-193189 (white dotted box: differentiated cell population). FIG. 10B shows the effect of LDN-193189 on the expression of phosphor-SMAD1 / 5. FIG. 10C shows the effect of LDN-193189 on the expression of phosphor-SMAD2 / 3. FIG. 10D shows the expression of genes related to pluripotency and mesodermal tissue development in porcine embryonic stem cells cultured on feeder cells treated with LDN-193189, as confirmed by qPCR.

[0113] Treatment with LDN-193189 reduced spontaneous differentiation of porcine embryonic stem cells cultured on feeder cells and enhanced the expression of SSEA4 markers. This is presumably due to suppression of SMAD1 / 5 signaling pathway involved in mesodermal differentiation and activation of SMAD2 / 3 signaling pathway involved in stem cell proliferation. qPCR analysis also confirmed that treatment with LDN-193189 reduced the expression of genes involved in various mesodermal tissue development.

Claims

1. A medium composition for culturing porcine pluripotent stem cells, comprising LDN-193189.

2. The medium composition for culturing porcine pluripotent stem cells according to claim 1, wherein the LDN-193189 is at a concentration of 10 nM to 1000 nM.

3. The medium composition for culturing porcine pluripotent stem cells according to claim 1, wherein the porcine pluripotent stem cells are porcine embryonic stem cells or porcine induced pluripotent stem cells.

4. The medium composition for culturing porcine pluripotent stem cells according to claim 1, which is for use in feeder cell-independent culture of porcine pluripotent stem cells.

5. The medium composition for culturing porcine pluripotent stem cells according to claim 4, wherein the feeder cell-independent culture is performed by culturing cells in a culture vessel coated with extracellular matrix (ECM) or Matrigel (registered trademark).

6. The medium composition for culturing porcine pluripotent stem cells according to claim 5, wherein the feeder cell-independent culture is performed by culturing the cells in a culture vessel coated with fibronectin, laminin, poly-L-lysine, type 1 collagen, or Matrigel (registered trademark).

7. The medium composition for culturing porcine pluripotent stem cells according to claim 1, further comprising FGF2, Activin A, CHIR99021 and IWR-1.

8. The medium composition for culturing porcine pluripotent stem cells according to claim 7, wherein the concentration of the FGF2 is 0.1 ng / ml to 100 ng / ml, the concentration of the activin A is 0.1 ng / ml to 10 ng / ml, the concentration of the CHIR99021 is 0.1 μM to 4.5 μM, and the concentration of the IWR-1 is 0.1 μM to 5 μM.

9. 2. The medium composition for culturing porcine pluripotent stem cells according to claim 1, which promotes proliferation of stem cells and inhibits cell death.

10. The medium composition for culturing porcine pluripotent stem cells according to claim 1, characterized in that the medium composition for culturing porcine pluripotent stem cells increases the number of stem cell colonies and increases the size of the colonies.

11. The medium composition for culturing porcine pluripotent stem cells according to claim 1, characterized in that the medium composition for culturing porcine pluripotent stem cells enhances the stem cell potential / totipotency of stem cells.

12. The medium composition for culturing porcine pluripotent stem cells according to claim 1, characterized in that the medium composition for culturing porcine pluripotent stem cells is serum-free or contains 0.1 to 3% by weight of a serum component.

13. A composition for use as an additive to a culture medium for porcine pluripotent stem cells, the composition comprising LDN-193189 as an active ingredient.

14. The composition for adding to a culture medium for porcine pluripotent stem cells according to claim 13, wherein the LDN-193189 is at a concentration of 10 nM to 1000 nM.

15. The method includes the step of treating porcine pluripotent stem cells with the medium composition for culturing porcine pluripotent stem cells according to claim 1 and culturing the same; The method for culturing porcine pluripotent stem cells, wherein the porcine pluripotent stem cells are porcine embryonic stem cells or porcine induced pluripotent stem cells.

16. 16. The method for culturing porcine pluripotent stem cells according to claim 15, wherein the culture is performed in a feeder cell-independent manner.

17. The method for culturing porcine pluripotent stem cells according to claim 16, wherein the feeder cell-independent culture is performed by culturing the cells in a culture vessel coated with extracellular matrix (ECM) or Matrigel.

18. The method for culturing porcine pluripotent stem cells according to claim 17, wherein the feeder cell-independent culture is performed by culturing the cells in a culture vessel coated with fibronectin, laminin, poly-L-lysine, type 1 collagen or Matrigel.

Citation Information

Patent Citations

  • Medium composition for culturing porcine pluripotent stem cells

    US20210102163A1

  • Production method for nerve tissue

    WO2016063985A1

  • Medium composition for culturing porcine pluripotent stem cell

    KR102142400B1